Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTOG 0617: High-dose vs Standard-dose Radiotherapy with Chemotherapy +/- Cetuximab in Stage III NSCLC
NCT00533949Phase 3Completed
- Sponsor
- NRG Oncology
- Start
- Nov 2007
- Primary completion
- Jun 2013
- Modality
- Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 3 trial of KL-140 in non-small cell lung cancer (NSCLC), sponsored by NRG Oncology. Started Nov 2007; status: completed.
02
Drugs
KL-140
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00533949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00533949.